We have recently shown that the inability of repetitive ischemia (RI) to activate p38 MAPK (p38) and Akt in metabolic syndrome [JCR:LA-cp (JCR)] rats was associated with impaired coronary collateral growth (CCG). Furthermore, Akt and p38 activation correlated with optimal O 2 Ϫ ⅐ levels and were altered in JCR rats, and redox-sensitive p38 activation was required for CCG. Here, we determined whether the activation of Src, a possible upstream regulator, was altered in JCR rats and whether redox-dependent Src and Akt activation were required for CCG. CCG was assessed by myocardial blood flow (microspheres) and kinase activation was assessed by Western blot analysis in the normal zone and collateral-dependent zone (CZ). RI induced Src activation (ϳ3-fold) in healthy [Wistar-Kyoto (WKY)] animals but not in JCR animals. Akt inhibition decreased (ϳ50%), and Src inhibition blocked RI-induced CCG in WKY rats. Src inhibition decreased p38 and Akt activation. Myocardial oxidative stress (O 2 Ϫ ⅐ and oxidized/reduced thiols) was measured quantitatively (X-band electron paramagnetic resonance). An antioxidant, apocynin, reduced RI-induced oxidative stress in JCR rats to levels induced by RI in WKY rats versus the reduction in WKY rats to very low levels. This resulted in a significant restoration of p38 (ϳ80%), Akt (ϳ65%), and Src (ϳ90%) activation in JCR rats but decreased the activation in WKY rats (p38: ϳ45%, Akt: ϳ65%, and Src: ϳ100%), correlating with reduced CZ flow in WKY rats (ϳ70%), but significantly restored CZ flow in JCR rats (ϳ75%). We conclude that 1) Akt and Src are required for CCG, 2) Src is a redox-sensitive upstream regulator of RI-induced p38 and Akt activation, and 3) optimal oxidative stress levels are required for RI-induced p38, Akt, and Src activation and CCG. signal transduction; oxidative stress; coronary artery disease; syndrome X CARDIAC ISCHEMIA-REPERFUSION INJURY is a biphasic process where the prolonged reduction in blood flow (ischemia) initiates myocardial cell death followed by further injury upon reperfusion, leading to stunning or necrosis. The massive amounts of ROS released during reperfusion have been implicated as the major cause of myocardial tissue death (25). In contrast, transient repetitive ischemia (RI) renders the myocardium tolerant to ischemia-reperfusion (16,20). The definitive driving force for coronary collateral growth (CCG) is still debated. Ischemia is a well-accepted stimulus for angiogenesis, but elevated fluid shear stress, resulting from occlusion-induced pressure gradients across the coronary circulation, has been proposed to drive collateral remodeling (13,27,34,35). None of these studies have definitively excluded ischemia as the contributing factor to collateral growth. The suggestion that ischemia is not a driving force for CCG rests on a single study (24) in a model of canine coronary occlusion, which observed only epicardial vascular growth while the subendocardium became ischemic.Several studies now support the view that RI is an important driving force for...